Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 950 of 1467 entries
View as:

A Phase I/Ib Trial for the Evaluation of SAR260301 in Monotherapy or in Combination With Vemurafenib in Patients With Various Advanced Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01673737 Org: User:
Start: 08/31/12 End: 02/28/15 Due: 02/28/16

Study of a Tetravalent Dengue Vaccine in Healthy Children Aged 2 to 11 Years in Malaysia

Phase: N/A Priority: Normal
NCT ID: NCT01254422 Org: User:
Start: 12/02/10 End: 01/31/13 Due: 01/31/14

Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis

Phase: N/A Priority: Normal
NCT ID: NCT01659138 Org: User:
Start: 08/31/12 End: 04/30/16 Due: 04/30/17

A Study to Compare Pharmacokinetics (PK) and Pharmacodynamics (PD) of SAR341402 to Insulin Aspart in Subjects With Type 1 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT03202875 Org: User:
Start: 11/14/12 End: 12/28/12 Due: 12/28/13

Observatory on Elderly Patients "Les S.AGES"

Phase: N/A Priority: Normal
NCT ID: NCT01065909 Org: User:
Start: 05/31/09 End: 09/30/14 Due: 09/30/15

A Study to Assess Efficacy and Safety of Nasacort® Nasal Spray in Comparison With Flixonase® Nasal Spray in Adults Suffering From Perennial Allergic Rhinitis (PAR)

Phase: N/A Priority: Normal
NCT ID: NCT03317015 Org: User:
Start: 11/30/16 End: 07/10/17 Due: 07/10/18

Telithromycin, Treating Adult Outpatients With Mild to Moderate Community-acquired Pneumonia (CAP) in High Bacterial Resistance Areas

Phase: N/A Priority: Normal
NCT ID: NCT00538018 Org: User:
Start: 01/31/03 End: 06/30/04 Due: 06/30/05

Study of XL147 (SAR245408) or XL765 (SAR245409) in Combination With Letrozole in Subjects With Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01082068 Org: User:
Start: 06/30/10 End: 04/30/13 Due: 04/30/14

Cabazitaxel and Abiraterone Acetate in Patients With Metastatic Castrate-Resistant Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01511536 Org: User:
Start: 03/31/12 End: 12/31/14 Due: 12/31/15

Comparison of Eplivanserin and Lormetazepam in the Treatment of Insomnia Characterized by Sleep Maintenance Difficulties

Phase: N/A Priority: Normal
NCT ID: NCT00679900 Org: User:
Start: 04/30/08 End: 03/31/09 Due: 03/31/10

A Study to Determine the Long-Term Safety, Tolerability and Biological Activity of SAR421869 in Patients With Usher Syndrome Type 1B

Phase: N/A Priority: Normal
NCT ID: NCT02065011 Org: User:
Start: 09/12/13 End: 06/13/31 Due: 06/13/32

Determine Whether Glycemic Control is Different Between Lantus & a 3rd Oral Agent When Failure With Other Treatment

Phase: N/A Priority: Normal
NCT ID: NCT00046462 Org: User:
Start: 11/30/01 End: 12/31/04 Due: 12/31/05

Efficacy and Safety of Alogliptin vs. Acarbose in Chinese Type 2 Diabetes Mellitus (T2DM) Patients With High CV Risk or CHD Treated With Aspirin and Inadequately Controlled With Metformin Monotherapy or Drug Naive

Phase: N/A Priority: Normal
NCT ID: NCT03794336 Org: User:
Start: 06/29/19 End: 12/14/20 Due: 12/14/21

Evaluation of the Effectiveness and Safety of Physician Versus Patient-led of Insulin Glargine Initiation and Titration in Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT01169818 Org: User:
Start: 08/31/10 End: 06/30/12 Due: 06/30/13

Repeated Dosing Study With a New Insulin Glargine Formulation and Lantus® in Patients With Type 1 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT01349855 Org: User:
Start: 03/31/11 End: 05/31/11 Due: 05/31/12

Efficacy and Safety of Eplivanserin Treatment for Sleep Maintenance Insomnia Followed by Optional Extension up to 1 Year

Phase: N/A Priority: Normal
NCT ID: NCT00253903 Org: User:
Start: 11/30/05 End: 09/30/08 Due: 09/30/09

Effect of Rimonabant and Metformin Combination on Glycemic Control in Patients With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00690456 Org: User:
Start: 05/31/08 End: 02/28/09 Due: 02/28/10

Dermacyd PH_DETINLYN Tangerine Mix (Lactic Acid) - Safety.

Phase: N/A Priority: Normal
NCT ID: NCT00785642 Org: User:
Start: 08/31/08 End: - Due: -

Alfuzosin for Treating Acute Urinary Retention

Phase: N/A Priority: Normal
NCT ID: NCT00336921 Org: User:
Start: 02/28/06 End: - Due: -

Phase I Dose Finding Study of SSR97225 Given in Patients With Refractory Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00547261 Org: User:
Start: 10/31/07 End: 08/31/08 Due: 08/31/09

A "Real World" Trial to Determine Efficacy and Health Outcomes of Toujeo Compared to "Standard of Care" Basal Insulins in Insulin Naïve Patients Initiating Insulin

Phase: N/A Priority: Normal
NCT ID: NCT02967224 Org: User:
Start: 11/05/15 End: 10/16/17 Due: 10/16/18

Multiple Ascending Dose Study To Assess The Safety Profile Of SAR113244 Versus Placebo In Lupus Male And Female Patients

Phase: N/A Priority: Normal
NCT ID: NCT02321709 Org: User:
Start: 11/30/14 End: 03/31/16 Due: 03/31/17

A Glycemic Control Evaluation of Glimepiride Versus Rimonabant on Top of Metformin in Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00449605 Org: User:
Start: 03/31/07 End: 03/31/09 Due: 03/31/10

Antibody Persistence and Response to Re-vaccination With Either Menactra® or Menomune® 3 Years After Initial Vaccination

Phase: N/A Priority: Normal
NCT ID: NCT01239043 Org: User:
Start: 11/30/10 End: 02/29/12 Due: 02/28/13

GETNA2 Neoadj. TAX+Femara vs Femara in g I/II Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00617968 Org: User:
Start: 10/31/03 End: 06/30/05 Due: 06/30/06